Morepen Laboratories Limited — Important, 31-03-2025: General Updates

Morepen Laboratories Limited has announced a board meeting regarding a significant change in the status of Dr. Morepen Limited from a “Wholly Owned Subsidiary” to a “Subsidiary.” This transition occurs after DML allotted 1,01,69,875 equity shares to related parties, reducing Morepen's shareholding from 100% to 80%. The shares arose from the conversion of fully convertible warrants, with a total value of Rs. 30.51 Cr.

This move indicates a strategic shift that may enhance collaboration with related entities while also raising concerns about reduced control. Investor sentiment may view this as a potential risk, but it also opens opportunities for dynamic partnerships.